- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.04. | NeurAxis, Inc.: NeurAxis Announces New Medical Policy Coverage in North Dakota | 1 | GlobeNewswire (USA) | ||
| 16.04. | Neuraxis, INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 16.04. | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 12.04. | NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 12.04. | NeurAxis reports Q4 results | 1 | Seeking Alpha | ||
| 09.04. | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 09.04. | NeurAxis, Inc.: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results | 58 | GlobeNewswire (Europe) | CARMEL, Ind., April 09, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic... ► Artikel lesen | |
| 01.04. | NeurAxis, Inc.: NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024 | 1 | GlobeNewswire (USA) | ||
| 01.04. | Neuraxis, INC - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 27.03. | NeurAxis, Inc.: NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry | 1 | GlobeNewswire (USA) | ||
| 11.03. | NeurAxis, Inc.: NeurAxis Announces Highmark BCBS Policy Coverage | 1 | GlobeNewswire (USA) | ||
| 11.03. | Neuraxis, INC - 8-K, Current Report | - | SEC Filings | ||
| 04.03. | NeurAxis, Inc.: NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage | 2 | GlobeNewswire (USA) | ||
| 27.02. | NeurAxis, Inc.: NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference | 1 | GlobeNewswire (USA) | ||
| 15.02. | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 31.01. | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 31.01. | NeurAxis, Inc.: NeurAxis Appoints Timothy Henrichs as Chief Financial Officer | 207 | GlobeNewswire (Europe) | CARMEL, Ind., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializing neuromodulation therapies that address... ► Artikel lesen | |
| 20.12.23 | NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer | 186 | GlobeNewswire (Europe) | CARMEL, Ind., Dec. 20, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializing neuromodulation therapies that address... ► Artikel lesen | |
| 19.12.23 | Neuraxis, INC - 8-K, Current Report | 1 | SEC Filings | ||
| 21.11.23 | NeurAxis reports Q3 results | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 52,05 | 0,00 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 32,540 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| ADAPTHEALTH | 10,130 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| ATRICURE | 23,370 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
| RXSIGHT | 53,26 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 24,300 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 10,910 | 0,00 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
| MIMEDX | 6,260 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
| SIEMENS HEALTHINEERS | 52,46 | -0,53 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,650 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,260 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2023 Results | SCOTTSDALE, Ariz., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| LIFEMD | 11,870 | 0,00 % | LifeMD, Inc.: LifeMD Appoints Dr. Calum MacRae to its Board of Directors | ||
| FRESENIUS | 27,820 | +0,51 % | DAX-Check LIVE: Airbus, Bayer, Deutsche Bank, Fresenius, Infineon, SAP im Fokus | Der DAX ist gestern erfolgreich in die neue Woche gestartet. Er legte um 0,6 Prozent zu und schloss damit bei 17.737 Punkten. Das Tageshoch lag sogar bei 17.889 Zählern. Worauf es jetzt für den DAX... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 5,080 | 0,00 % | Demystifying Alignment Healthcare: Insights From 4 Analyst Reviews | ||
| NANO-X IMAGING | 8,980 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen |
Das Unternehmen NEURAXIS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,210 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
